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Abstract 
Small  leucine-rich  repeat  proteoglycans
(SLRP) are present in the extracellular matrix
of  the  temporomandibular  joint  (TMJ)  disc.
Lumican and fibromodulin, classified as class
2 SLRPs, play important roles in TMJ assembly,
proliferation and inflammation. Degenerative
change  in  the  TMJ  disc  gives  rise  to  the
process of internal derangement (ID). In this
study,  we  immunohistochemically  examined
the expression of lumican and fibromodulin in
nine human TMJ specimens and examined the
gene expression of both proteoglycans in cul-
tured human TMJ disc cells under interleukin-
1 beta (IL-1 b)-stimulated conditions. An artic-
ular disc cell line was established by collage-
nase treatment of a TMJ disc. The subcultured
cells were then incubated for 1, 3, 6, 12, 24 or
48 h under both normal and IL-1 b (1 ng/mL)
conditions.  The  gene  expression  of  lumican
and  fibromodulin  was  examined  using  the
reverse  transcription-polymerase  chain  reac-
tion  (RT-PCR)  and  real-time  RT-PCR.  We
demonstrated that the expression of lumican
significantly differs from that of fibromodulin
in the deformed disc and that IL-1 b induces a
significant increase in lumican mRNA, but not
in fibromodulin mRNA, after 24~48 h culture
compared to cells cultured in the absence of IL-
1 b (P<0.05). These results indicate that lumi-
can and fibromodulin display different behav-
iors and that lumican may promote regenera-
tion of the TMJ after degeneration and defor-
mation induced by IL-1 b.
Introduction
Recent studies have showed the pathologi-
cal  changes  of  human  temporomandibular
joint (TMJ) discs affected by internal derange-
ment (ID).1,2
The extracellular matrix in the articular disc
of TMJ is composed mainly of collagen, gly-
cosaminoglycans (GAGs) and proteoglycans.3,4
Furthermore, proteoglycan (decorin, biglycan,
fibromodulin) mRNA has been reported to be
expressed in TMJ discs.5 We previously report-
ed that the proteoglycan lumican is expressed
in  human  TMJ  discs  and  that  it  is  strongly
expressed  in  deformed  discs.6 Lumican  and
fibromodulin  are  class  2  small  leucine-rich
repeat proteoglycans (SLRPs) that contain pri-
marily  keratan  sulfate,  and  their  respective
genes  have  a  similar  exonic  organization
(three exons), with a large central exon encod-
ing most of the leucine-rich repeats (LRRs).7
Recent  studies  have  shown  that  lumican  is
also expressed in tissues such as the cornea,
the intervertebral disc and in tendons and that
it plays a significant role in the assembly and
regulation of collagen fibers.8-13 Lumican that
is expressed in injured epithelium is reported
to modulate cell behavior such as adhesion or
migration,  thereby  contributing  to  corneal
epithelial  wound  healing.14 Gene  expression
analysis by cDNA array and RT-PCR demon-
strated higher lumican mRNA levels in scoliot-
ic discs vs. normal discs.15 Fibromodulin has
been reported to be expressed in a number of
tissues,  including  the  epidermis,  interverte-
bral  discs,  tendons,  and  the  TMJ  disc.16-19
Growth, aging, and degeneration of the inter-
vertebral disc are associated with changes in
the abundance and structure of fibromodulin
and lumican.11
Internal derangement of TMJ is a progres-
sive disorder with an abnormal anatomic rela-
tionship  of  the  TMJ  disc  to  the  mandibular
condyle, articular eminence and glenoid fossa.
The  process  of  ID  of  TMJs  is  caused  by
cytokines [interleukin-1 beta (IL-1 b), TGF-b,
TNF-a], trauma, functional overloading, joint
laxity, lack of lubrication or hyperactivity of the
lateral  pterygoid  muscle.  The  TMJ  deformed
disc is considered to cause the degeneration
and  deformation  that  occurs  during  the
process of ID.20
Recent studies showed that IL-1 bis predom-
inantly localized in synovial lining cells and in
the  endothelial  cells  of  blood  vessels.21-24
Furthermore, IL-1 b is secreted not only from
synovial  membranes  but  also  from  activated
macrophages and from a variety of other cell
types  and  elicits  many  biological  responses,
including thymocyte proliferation, wound heal-
ing, and tissue resorption.25 Therefore, IL-1 b
may play a particularly important role in the
process of ID. The aim of this study was to
compare the expression of lumican and fibro-
modulin in the deformed disc and to analyze a
role for IL-1 b in the regulation of these pro-
teins in cultured human TMJ disc cells.
We therefore compared the protein expres-
sion of lumican and fibromodulin in deformed
discs  of  TMJ  using  immunohistochemical
staining and analyzed the effect of IL-1 b stim-
ulation on the gene expression of lumican and
fibromodulin in cultured human TMJ disc cells
using the polymerase chain reaction (PCR).
Materials and Methods
Immunohistochemical analysis
Nine TMJ discs were investigated (Table 1).
The patients’ ages ranged from 20 to 72 years,
with a mean age of 49.8 years. We treated the
patients  using  conservative  treatment,  and
only carried out open surgery on patients for
whom conservative treatment was unsuccess-
ful. All discs were macroscopically deformed,
and none of the discs had a normal biconcave
shape. We evaluated the nine TMJ discs using
the  histopathological  degeneration  grading
score system. All nine TMJ discs displayed a
severe grade of degeneration.26 The patients
did  not  have  a  history  of  trauma  to  the
mandible, and none of them had ankylosis. All
the patients gave complete informed consent
for the surgery and the use of their tissue in
the  research,  which  was  approved  by  the
Human Reserch Ethics Committee, Wakayama
Medical University.
The specimens were fixed overnight in 4%
paraformaldehyde, embedded in paraffin wax,
and  cut  to  obtain  5-ʼm-thick  sections.  For
immunohistochemical  staining,  the  sections
were  dewaxed  in  xylene  and  rehydrated  in
serial  alcohol.  Endogenous  peroxidase  was
blocked  by  immersing  the  sections  in  0.3%
H2O2 in methanol for 20 min at room tempera-
ture.  The  specimens  were  blocked  with  3%
skimmed  milk  [0.01%  Tween-phosphate-
buffered  saline  (PBS)]  for  60  min  at  room
temperature and were then treated using rab-
bit  polyclonal  antibodies  against  lumican
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(Wakayama  Medical  University,  Wakayama,
Japan) and fibromodulin (University of South
Florida, Tampa, FL, USA) at 4°C for 12 h. The
anti-lumican and the anti-fibromodulin poly-
clonal antibodies were used at a dilution of
1:800 and 1:400. After washing with PBS, the
specimens were treated with horseradish per-
oxidase-labelled  anti-rabbit  IgG  antibody
(Dako, Glostrup, Denmark) for 60 min at room
temperature. The colour was developed using
3,3’-diaminobenzidine/H2O2 solution  followed
by counterstaining with Mayer’s hematoxylin.
The  negative  controls  were  subjected  to  the
same  protocol  except  that  PBS  was  used
instead of the primary antibody.
Cultivation of temporomandibular
joint disc cells
Cell  culture  of  TMJ  disc  tissue  obtained
from  a  patient  with  synovial  osteochondro-
matosis was performed as follows. The patient
provided informed consent, and the study was
approved  by  the  Ethics  Committee  of
Wakayama Medical University. Thin sections
of the disc tissue were cut and immersed in
0.25% trypsin and 0.25 mM EDTA (Gibco-BRL,
Life Technologies Inc., Grand Island, NY, USA)
for  20  min  followed  by  collagenase  (Roche
Diagnostics, Mannheim, Germany) treatment
for 3 h. The tissues were then washed with
Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco-BRL, San Francisco, CA, USA) contain-
ing 10% fetal bovine serum (FBS) (Equitech-
Bio  Inc.,  Kerrville,  TX,  USA)  and  1%  peni-
cillin/streptomycin  (Gibco-BRL).  The  cells
were grown at 37°C in a humidified 5% CO2
atmosphere, and were passaged every 14 days.
All experiments were carried out on cells at
passage 5.
The cell culture and IL-1 treatment protocols
used in this study were validated in a previous
study.27 In brief, the cells were plated at a den-
sity of 1×106/well in 6-well plates (Iwaki, Asahi
Techno Glass, Funabashi, Japan) in the above
10% FBS-containing medium. Once the cells
became confluent, the medium was changed to
serum-free medium and the cells were incu-
bated for 24 h. The cultures were rinsed with
phosphate-buffered saline (PBS), and then 2
mL of fresh serum-free medium, with or with-
out 1 ng/mL of IL-1 b (PeproTech, London, UK)
was added, and the cells were incubated for a
further 1, 3, 6, 12, 24 or 48 h in a humidified
atmosphere of 20% O2, 5% CO2 and 75% N.
Reverse transcription-polymerase
chain reaction 
Total  RNA  was  isolated  from  the  cultured
cells  using  an  RNeasy® Mini  Kit  (Qiagen,
Valencia, CA, USA). The first strand cDNA was
synthesized  from  0.5  ʼg  of  total  RNA  using
SuperScript® transcriptase  (Invitrogen,
Carlsbad,  CA,  USA).  The  reactions  were
primed with Oligo (dT) 12-18 primers and the
total volume was 20 ʼL. RT-PCR analysis was
performed in a total volume of 50 ʼL using Taq.
DNA  polymerase  (Ampli  Taq  Gold®,  Applied
Biosystems, Foster City, CA, USA) and 1 ʼL of
the cDNA sample as a template. PCR amplifica-
tion was performed for 35 cycles (denatura-
tion: 95°C for 30 s; annealing: 60°C for 60 s;
extension: 72 °C for 120 s). Table 2 shows the
primer sequences used for this study. The PCR
products  were  electrophoresed  on  a  2%
agarose  gel  and  were  visualized  following
ethidium bromide staining using a densitome-
ter (Atto, Tokyo, Japan). All experiments were
performed three times.
Real-time polymerase chain reaction
Total RNA was isolated from TMJ disc cells
using  the  RNeasy® Mini  Kit  (Qiagen),  as
described in the protocol provided with the kit.
First-strand cDNA was synthesized from 1 ʼg
of total RNA using the SuperScript® transcrip-
tase (Invitrogen). The reactions were primed
with Oligo (dT) primers and the total volume
was 20 ʼL. RT-PCR was performed using the
BIO-RAD iCycler iQ system (Bio Rad, Hercules,
CA,  USA)  according  to  the  manufacturer’s
instructions. The reactions were performed in
a total volume of 50 ʼL using the iQ SYBR
Green Supermix (Bio Rad); 0.5 ʼL of cDNA
sample was used as a template. Cycling was
started with an activation step at 95°C for 3
min,  and  the  amplification  program  was
repeated 45 times (denaturation: 95°C for 15 s;
annealing: 60°C for 30 s; extension: 72°C for
30 s) with fluorescence measurement at 72°C.
All  samples  were  run  in  triplicate  with  the
internal  control  [18S  ribosomal  RNA  (18S
rRNA)] and the target gene (Table 2) on the
same plate. The fluorescence threshold value
was calculated using the iCycle iQ system soft-
ware  version  3.0A.  To  confirm  amplification
specificity, the PCR products from each primer
pair were subjected to a melting curve analy-
sis. Real-time PCR efficiencies for each reac-
tion  were  calculated  using  the  formula
Efficiency (E)=10[–1/slope], from the slope values
given in the iCycle iQ system software. The
ΔCt values for the reference gene (18S rRNA)
and the target gene were calculated by sub-
tracting the value of the experimental group
(normal or IL-1 b-treated). The mathematical
model presented by Pfaffl was used to deter-
mine the relative quantification of the target
gene in comparison to the reference gene. The
relative expression ratio (R) of the target gene
was calculated based on E and the ʔCt of the
experimental group versus the control, and is
expressed in comparison to 18S rRNA.
Statistical analysis
All  values  are  expressed  as  the  means  of
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Table 1. Clinical data of patients.
Sample Sex Age Diagnosis Symptom Mouth max Displacement of 
no. (years) (pain) opening (mm)
TMJ disc
1 Female 20 ID – OA + 32 +
2 Female 58 ID – OA  + 45 +
3 Female 52 ID – OA + 25 +
4 Male 72 ID – OA + 18 +
5 Female 72 ID – OA + 39 +
6 Male 64 ID – OA - 37 +
7 Female 52 ID – OA + 30 +
8 Female 24 ID – OA + 15 +
9 Female 34 ID – OA - 20 +
TMJ, temporomandibular joint; ID, internal derangement; OA, osteoarthritis.
Table 2. Details of polymerase chain reaction primers used in the present study. 
Gene Accession no. Primer
Fibromodulin NM_002023 F, 5’ –GGGGCAAGGACTGTTGGAGGAG-3’
R, 5’ –CCAGGTCTGGAGCC-3’
Lumican U21128 F, 5’ –CCACCACACCTGACAGAGT-3’
R, 5’ –CAAGTTGATTGACCTCCAGG-3’
18S rRNA BX296557 F, 5’ –GTTGGTGGAGCGATTTGTCT-3’
R, 5’ –GGCCTCACTAAACCATCCAA-3’[European Journal of Histochemistry 2011; 55:e11] [page 65]
three experiments ± S.D. The statistical sig-
nificance  was  evaluated  using  one-way
ANOVA. P-values less than 0.05 were consid-
ered significant. Satistical analysis was per-
formed  using  Excel  X  for  Mac  (Microsoft,
Redmond, WA, USA) with the add-in softwave
Statcel 2 (OMS, Tokyo, Japan).
Results
Immunohistochemical analysis 
of lumican and fibromodulin 
in deformed temporomandibular
joint discs
We first compared the protein expression of
lumican  and  fibromodulin  in  the  deformed
discs using immunohistochemistry. The discs
did not have a normal biconcave shape (Figure
1 A). Fibromodulin was expressed in areas of
weak lumican expression (Figure 1 B,C) and
was  also  expressed  adjacent  to  the  area  of
strong  lumican  expression  (Figure  1  D,E).
Strong lumican expression was observed over
a large area of the disc surface (Figure 1 F).
Fibromodulin expression was localized slightly
below the disc surface (Figure 1 G). 
The effect of IL-1 b treatment 
on lumican and fibromodulin
expression in temporomandibular
joint cells
To  evaluate  the  potential  contribution  of
lumican and fibromodulin to TMJ disc disrup-
tion  during  inflammation,  we  evaluated  the
effect of IL-1 b treatment of TMJ cells on the
mRNA  expression  of  lumican  and  fibromod-
ulin.  Their  mRNA  expression  was  assayed
using RT-PCR (Figure 2) and was quantified
using real-time PCR (Figure 3) following incu-
bation with 1 ng/mL IL-1 b over 48 h. IL-1 b
induced  a  significant  increase  in  lumican
mRNA after 24~48 h incubation compared to
the level in cells grown in the absence of IL-1 b
(P<0.05). There were no significant changes
in the gene expression of fibromodulin in the
presence or absence of IL-1 b (Figures 2, 3).
Discussion
In the present study, we performed both in
vitro and in vivo studies of the TMJ disc. We
have shown that, although both lumican and
fibromodulin are expressed in the deformed
TMJ disc, IL-1 b enhances lumican, but not
fibromodulin  mRNA  expression.  It  is  known
that lumican and fibromodulin compete for the
same binding sites on collagen fibrils of ECM
and that fibromodulin has higher affinity for
these sites than lumican.28 Ezura et al. have
proposed  that  developmental  stage-specific
functions are mediated by differential expres-
sion patterns of lumican and fibromodulin.29
Thus, lumican expression decreases to barely
detectable levels during the progression of fib-
rillogenesis, whereas fibromodulin expression
significantly increases during this process. In
another  study,  it  was  reported  that  the
immunostaining  intensity  of  lumican  had
increased in the migrating epithelium 3 days
after wounding, whereas the staining intensi-
ty of fibromodulin was reduced in the migrat-
ing  epithelium.  However,  in  that  study,  the
staining intensity of fibromodulin was gradu-
ally increased to high levels when the migrat-
ing epithelial fronts had joined and started to
undergo maturation.30 Therefore, our data are
similar to the differential, inverse modulation
of lumican and fibromodulin reported for other
systems. The combined data suggest that lumi-
can and fibromodulin have a complementary
relationship during tissue remodeling.
In  our  study,  the  synthesis  of  lumican
mRNA,  but  not  that  of  fibromodulin  mRNA,
increased under IL-1 b-stimulated conditions
from 12 h onward. The lack of effect of IL-1 on
fibromodulin mRNA is consistent with previ-
ous reports that IL-1 has no significant effects
on the levels of fibromodulin mRNA in cultured
fibroblasts from fetal skin and bovine sclera.31
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Figure  1.  Immunohistochemical  analysis  of  Lumican  (LUM)  and  fibromodulin  (FM)
expression in the deformed disc. (A) Hematoxylin and eosin stain of the deformed TMJ
disc.  (B)  Strong  lumican  expression  and  weak  lumican  expression  (arrows)  in  the
deformed part of the disc (enlargement of the circle in Figure 1 A). (C) Localized fibro-
modulin expression at sites of weak lumican expression (arrows) (enlargement of the rec-
tangle in Figure 1 A). (D) Strong lumican expression in the deformed part of the disc. (E)
Fibromodulin expression in the deformed part of the disc. (F) High power of the boxed
region in the lumican-stained panel D. (G) High power of the boxed region in the fibrob-
modulin-stained panel E (scale bars: A, 1000 µm; B-E, 200 µm; F and G, 50 µm).[page 66] [European Journal of Histochemistry 2011; 55:e11]
However, C1q binds to an N-terminal fragment
of fibromodulin and this binding has been sug-
gested to play a role in IL-1 stimulation of car-
tilage.  Fibromodulin  that  is  a  component  of
cartilage has the ability to activate an inflam-
matory cascade, i.e., complement.32 There  fore,
lumican and fibromodulin may function in dif-
ferent processes that are involved in cellular
adjustment to a changed external environment
such as extracellular matrix assembly, prolifer-
ation  and  inflammation.  Based  on  previous
reports in other systems, it is likely that lumi-
can mRNA will show a gradual decrease, and
fibromodulin mRNA will show an increase, or
no change, if IL-1 b stimulation of cultured
human TMJ disc cells is extended for a much
longer time than the time used in this study.
However, this possibility remains to be experi-
mentally  confirmed.  Our  data  suggest  that
lumican, but not fibromodulin, may function in
the rapid adjustment of TMJ cells to a change
in the environment, especially to changes due
to inflammation. However, it cannot be exclud-
ed that fibromodulin levels may increase, and
play a role, at later stages of this adjustment.
In conclusion, we have shown that lumican
and fibromodulin are differentially expressed
in the deformed TMJ disc. Although lumican
and  fibromodulin  mRNA  are  both  expressed
under IL-1 b-stimulated conditions in cultured
human  TMJ  disc  cells,  the  level  of  lumican
mRNA, but not that of fibromodulin mRNA, is
enhanced  by  IL-1 b.  These  findings  suggest
that lumican and fibromodulin are differential-
ly  regulated  and  that  lumican  may  promote
regeneration of the TMJ following the degen-
eration and deformation induced by IL-1 b. 
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